Omicron variant resembles other respiratory viruses, posing challenges for syndromic surveillance

Novartis and PeptiDream will develop peptide-based radioligand therapies and diagnostics under the latest deal. Credit: Taljat David / Shutterstock.com. Novartis and Japanese biopharmaceutical company PeptiDream

Healthcare and related issues might not have been a major focus of Monday night’s proceedings at the Republican National Convention in Milwaukee, but they were